Globus Medical Inc
NYSE:GMED

Watchlist Manager
Globus Medical Inc Logo
Globus Medical Inc
NYSE:GMED
Watchlist
Price: 70.7 USD -1.68% Market Closed
Market Cap: 9.7B USD
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Loading...
Revenue
Loading...
Operating Income
Loading...
Net Income
Loading...

Wall Street
Price Targets

GMED Price Targets Summary
Globus Medical Inc

Wall Street analysts forecast GMED stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for GMED is 99.41 USD with a low forecast of 80.8 USD and a high forecast of 120.75 USD.

GMED Lowest Forecast
Wall Street Target
80.8 USD
14% Upside
GMED Average Forecast
Wall Street Target
99.41 USD
41% Upside
GMED Highest Forecast
Wall Street Target
120.75 USD
71% Upside
Lowest
Price Target
80.8 USD
14% Upside
Average
Price Target
99.41 USD
41% Upside
Highest
Price Target
120.75 USD
71% Upside
Globus Medical Inc Competitors:
Price Targets
N
NAM
Namwiwat Medical Corp PCL
44% Upside
DCTH
Delcath Systems Inc
91% Upside
4595
Mizuho Medy Co Ltd
38% Downside
S
STIL
Stille AB
63% Upside
N
NAM
Namwiwat Medical Corp PCL
44% Upside
DCTH
Delcath Systems Inc
91% Upside
4595
Mizuho Medy Co Ltd
38% Downside
S
STIL
Stille AB
63% Upside
EUZ
Eckert & Ziegler Strahlen und Medizintechnik AG
6% Upside
BIM
Biomerieux SA
9% Upside
OWLT
Owlet Inc
160% Upside
4543
Terumo Corp
20% Upside

Revenue
Forecast

Revenue Estimate
Globus Medical Inc

For the last 8 years the compound annual growth rate for Globus Medical Inc's revenue is 21%. The projected CAGR for the next 3 years is 8%.

21%
Past Growth
8%
Estimated Growth
Estimates Accuracy
-1%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Globus Medical Inc

For the last 8 years the compound annual growth rate for Globus Medical Inc's operating income is 4%. The projected CAGR for the next 3 years is 54%.

4%
Past Growth
54%
Estimated Growth
Estimates Accuracy
-12%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Globus Medical Inc

For the last 8 years the compound annual growth rate for Globus Medical Inc's net income is 0%. The projected CAGR for the next 3 years is 81%.

0%
Past Growth
81%
Estimated Growth
Estimates Accuracy
-39%
Average Miss
What are analyst estimates?

See Also

Summary
GMED intrinsic value, competitors valuation, and company profile.
DCF Valuation
GMED stock valuation using Discount Cash Flow valuation method.
Relative Valuation
GMED stock valuation using valuation multiples.
Wall Street Estimates
GMED price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
GMED stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is GMED's stock price target?
Price Target
99.41 USD

According to Wall Street analysts, the average 1-year price target for GMED is 99.41 USD with a low forecast of 80.8 USD and a high forecast of 120.75 USD.

What is Globus Medical Inc's Revenue forecast?
Projected CAGR
8%

For the last 8 years the compound annual growth rate for Globus Medical Inc's revenue is 21%. The projected CAGR for the next 3 years is 8%.

What is Globus Medical Inc's Operating Income forecast?
Projected CAGR
54%

For the last 8 years the compound annual growth rate for Globus Medical Inc's operating income is 4%. The projected CAGR for the next 3 years is 54%.

What is Globus Medical Inc's Net Income forecast?
Projected CAGR
81%

For the last 8 years the compound annual growth rate for Globus Medical Inc's net income is 0%. The projected CAGR for the next 3 years is 81%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 252,600+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.